Experience. Commitment. Results.
Applied Molecular Transport Inc. (Nasdaq: AMTI), relating to its proposed sale to Cyclo Therapeutics, Inc. Under the terms of the agreement, AMTI shareholders are expected to receive 0.174 shares of Cyclo per share they own.
Splunk Inc. (Nasdaq: SPLK), relating to its proposed sale to Cisco Systems, Inc. Under the terms of the agreement, SPLK shareholders are expected to receive $157.00 in cash per share they own.
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), relating to its proposed sale to Alfasigma S.p.A. Under the terms of the agreement, ICPT shareholders are expected to receive $19.00 in cash per share they own.
Cambridge Bancorp (Nasdaq: CATC), relating to its proposed sale to Eastern Bankshares, Inc. Under the terms of the agreement, CATC shareholders will receive 4.956 shares of Eastern per share they own.
PFSweb, Inc. (Nasdaq: PFSW), relating to its proposed sale to GXO Logistics, Inc. Under the terms of the agreement, PFSW shareholders will receive $7.50 in cash per share they own.
Hostess Brands, Inc. (Nasdaq: TWNK), relating to its proposed sale to The J. M. Smucker Company. Under the terms of the tender offer, TWNK shareholders are expected to receive 0.03002 shares of Smucker and $30.00 in cash per share they own.
Avantax, Inc. (Nasdaq: AVTA), relating to its proposed acquisition by Aretec Group, Inc. Under the terms of the agreement, AVTA shareholders are expected to receive $26.00 in cash per share they own.
WestRock Co. (NYSE: WRK), relating to its proposed sale to Smurfit Kapp Group plc. Under the terms of the agreement, WRK shareholders are expected to receive 1 new share of the newly combined company, Smurfit WestRock, and $5.00 in cash per share they own.
NextGen Healthcare, Inc. (Nasdaq: NXGN), relating to its proposed sale to Thoma Bravo. Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.
Acer Therapeutics, Inc. (Nasdaq: ACER), relating to its proposed merger with Zevra Therapeutics, Inc. Under the terms of the agreement, ACER shareholders are expected to receive 0.121 shares of Zevra per share they own, plus the possibility of additional non-transferable CVRs.